The company expects to receive approval from the U.S. drug regulators for a treatment for atopic dermatitis—or eczema—by the ...

The US Food and Drug Administration (FDA) has approved Galderma's monoclonal antibody, Nemluvio (nemolizumab), for ...

Several Galderma Group AG shareholders are offering about a 6.7% stake in the skincare group that could raise around 1.28 billion Swiss francs ($1.45 billion), according to terms of the deal seen ...